Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,505-3,516 of 4,306
Drug study icon
CompletedNCT00892489

A Bioequivalence Study of 15 mg ER OROS Paliperidone

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00137267

A Brief Community Linkage Intervention for Dually Diagnosed Individuals

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bedford
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Addiction, ...BehavioralOver 18 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia, Addiction, ...
Drug study icon
TerminatedNCT01592201

Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER for Schizophrenia

This study was terminated in South Korea. It is testing Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER for Schizophrenia.

Multiple locations, including Busan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Drug study icon
CompletedNCT01682161

Evolution of Medication Satisfaction and Adherence for Schizophrenia

This study is completed in South Korea. It is testing evolution of Medication Satisfaction and Adherence for Schizophrenia.

Multiple locations, including Buchun
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03024203

A Comparison of Cognitive Training Approaches in Psychotic Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Kingston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Queen's University
Condition
Schizophrenia
Drug study icon
CompletedNCT00796835

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.